Fig. 19.
Schematic diagram of in-situ formation of ROS-responsive scaffold for local release of GEM and an anti–PD-L1 blocking antibody (aPDL1) with distinct release kinetics [169]. Copyright 2018, American Association for the Advancement of Science. GEM, gemcitabine; ROS, reactive oxygen species.